Literature DB >> 19267171

No evidence for association between an MAOA functional polymorphism and susceptibility to Parkinson's disease.

Caroline Williams-Gray, An Goris, Thomas Foltynie, Alastair Compston, Stephen Sawcer, Roger A Barker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19267171     DOI： 10.1007/s00415-009-0899-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

1.  Pedigree disequilibrium tests for multilocus haplotypes.

Authors:  Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2003-09       Impact factor: 2.135

2.  A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.

Authors: 
Journal:  Arch Neurol       Date:  2004-04

3.  Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors.

Authors:  Julia K Pinsonneault; Audrey C Papp; Wolfgang Sadée
Journal:  Hum Mol Genet       Date:  2006-08-07       Impact factor: 6.150

4.  High-resolution whole-genome association study of Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Timothy G Lesnick; Kari J Strain; Matthew J Farrer; Walter A Rocca; P V Krishna Pant; Kelly A Frazer; David R Cox; Dennis G Ballinger
Journal:  Am J Hum Genet       Date:  2005-09-09       Impact factor: 11.025

Review 5.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

6.  Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.

Authors:  C H Williams-Gray; A Goris; T Foltynie; J Brown; M Maranian; A Walton; D A S Compston; S J Sawcer; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

7.  Deprenyl's effect at slowing progression of parkinsonian disability: the DATATOP study. The Parkinson Study Group.

Authors:  P A LeWitt
Journal:  Acta Neurol Scand Suppl       Date:  1991

8.  Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  R E Heikkila; M V Kindt; P K Sonsalla; A Giovanni; S K Youngster; K A McKeown; T P Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  In vitro assays fail to predict in vivo effects of regulatory polymorphisms.

Authors:  Elizabeth T Cirulli; David B Goldstein
Journal:  Hum Mol Genet       Date:  2007-06-12       Impact factor: 6.150

10.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data.

Authors:  Hon-Chung Fung; Sonja Scholz; Mar Matarin; Javier Simón-Sánchez; Dena Hernandez; Angela Britton; J Raphael Gibbs; Carl Langefeld; Matt L Stiegert; Jennifer Schymick; Michael S Okun; Ronald J Mandel; Hubert H Fernandez; Kelly D Foote; Ramón L Rodríguez; Elizabeth Peckham; Fabienne Wavrant De Vrieze; Katrina Gwinn-Hardy; John A Hardy; Andrew Singleton
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182
View more
  3 in total

1.  Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease.

Authors:  Perdita Cheshire; Kelly Bertram; Helen Ling; Sean S O'Sullivan; Glenda Halliday; Catriona McLean; Jose Bras; Tom Foltynie; Elsdon Storey; David R Williams
Journal:  Neurodegener Dis       Date:  2013-09-05       Impact factor: 2.977

Review 2.  The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease.

Authors:  Daniele Caligiore; Flora Giocondo; Massimo Silvetti
Journal:  IBRO Neurosci Rep       Date:  2022-09-26

3.  Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.

Authors:  Jolanta Dorszewska; Michal Prendecki; Anna Oczkowska; Agata Rozycka; Margarita Lianeri; Wojciech Kozubski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.